N-Acetylcysteine Attenuates Diabetic Myocardial Ischemia Reperfusion Injury through Inhibiting Excessive Autophagy

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Wang, Sheng ^a   Wang, Chunyan ^b   Yan, Fuxia ^c   Wang, Tingting ^d   He, Yi ^a   Li, Haobo ^d   Xia, Zhengyuan ^d   Zhang, Zhongjun ^b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b JINAN UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CARDIOVASCULAR AGENT; CASPASE 3; CREATINE KINASE MB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SEQUESTOSOME 1; TUMOR NECROSIS FACTOR; 15-F2T-ISOPROSTANE; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HEART PROTECTION; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TUNEL ASSAY;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; AUTOPHAGY; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; IN SITU NICK-END LABELING; ISOPROSTANES; MALE; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 85013392353     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2017/9257291     Document Type: Article

References (40)

1. H. J. Whittington, G. G. Babu, M. M. Mocanu, D. M. Yellon, and D. J. Hausenloy, "The diabetic heart: too sweet for its own good" Cardiology Research and Practice, vol. 2012, Article ID 845698, 15 pages, 2012
2. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury," New England Journal of Medicine, vol. 357, no. 11, pp. 1121-1135, 2007
3. Z. Xia, H. Li,M.G. Irwin, and S. Howell, "Myocardial ischaemia reperfusion injury: The challenge of translating ischaemic and anaesthetic protection from animal models to humans," British Journal ofAnaesthesia, vol. 117, supplement 2, pp. ii44-ii62, 2016
4. G.Morciano, C. Giorgi,M. Bonora et al., "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury," Journal of Molecular and Cellular Cardiology, vol. 78, pp. 142-153, 2015
5. J. Chen, J. Gao,W. Sun et al., "Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts," International Journal of Cardiology, vol. 220, pp. 681-692, 2016
6. W. Krzyzanowska, B. Pomierny, B. Budziszewska, M. Filip, and J. Pera, "N-acetylcysteine and ceftriaxone as preconditioning strategies in focal brain ischemia: influence on glutamate transporters expression," Neurotoxicity Research, vol. 29, no. 4, pp. 539-550, 2016
7. T. Wang, X. Mao, H. Li et al., "N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes," Free Radical Biology and Medicine, vol. 63, pp. 291-303, 2013
8. X.Mao, T.Wang, Y. Liu et al., "N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1/HO-1 signaling in diabetic rats," PLoS ONE, vol. 8, no. 7, Article ID e68949, 2013
9. Y.Mei,M. D.Thompson, R. A. Cohen, and X.Tong, "Autophagy and oxidative stress in cardiovascular diseases," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1852, no. 2, pp. 243-251, 2015
10. Y. Fuchs and H. Steller, "Programmed cell death in animal development and disease," Cell, vol. 147, no. 4, pp. 742-758, 2011
11. S. Yang, X.Wang, G. Contino et al., "Pancreatic cancers require autophagy for tumor growth," Genes and Development, vol. 25, no. 7, pp. 717-729, 2011
12. T. Hidvegi, M. Ewing, P. Hale et al., "An autophagy-enhancing drug promotes degradation of mutant 1-antitrypsin Z and reduces hepatic fibrosis," Science, vol. 329, no. 5988, pp. 229-232, 2010
13. A.Nakai,O. Yamaguchi, T. Takeda et al., "Therole of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress," Nature Medicine, vol. 13, no. 5, pp. 619-624, 2007
14. P. Codogno and A. J. Meijer, "Autophagy: A potential link between obesity and insulin resistance," CellMetabolism, vol. 11, no. 6, pp. 449-451, 2010
15. A. Shirakabe, Y. Ikeda, S. Sciarretta, D. K. Zablocki, and J. Sadoshima, "Aging and autophagy in the heart," Circulation Research, vol. 118, no. 10, pp. 1563-1576, 2016
16. H. W. Virgin and B. Levine, "Autophagy genes in immunity," Nature Immunology, vol. 10, no. 5, pp. 461-470, 2009
17. B. J.Maron,W. C. Roberts, M. Arad et al., "Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy," The Journal of the American Medical Association, vol. 301, no. 12, pp. 1253-1259, 2009
18. M. A. Paiva, Z. Rutter-Locher, L. M. Gonçalves et al., "Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury," American Journal of Physiology, vol. 300, no. 6, pp. H2123-H2134, 2011
19. H. Takagi, Y. Matsui, S. Hirotani, H. Sakoda, T. Asano, and J. Sadoshima, "AMPK mediates autophagy during myocardial ischemia in vivo," Autophagy, vol. 3, no. 4, pp. 405-407, 2007
20. C. H. Jung, S.-H. Ro, J. Cao,N.M.Otto, and D.-H. Kim, "mTOR regulation of autophagy," FEBS Letters, vol. 584, no. 7, pp. 1287-1295, 2010
21. S. Sciarretta, N. Hariharan, Y. Monden, D. Zablocki, and J. Sadoshima, "Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart" Pediatric Cardiology, vol. 32, no. 3, pp. 275-281, 2011
22. L.Guo, J.-M.Xu, and X.-Y.Mo, "Ischemic postconditioning regulates cardiomyocyte autophagic activity following ischemia/reperfusion injury," Molecular Medicine Reports, vol. 12, no. 1, pp. 1169-1176, 2015
23. Z. V. Varga, Z. Giricz, L. Liaudet, G. Haskó, P. Ferdinandy, and P. Pacher, "Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy," Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1852, no. 2, pp. 232-242, 2015
24. P. E. Munasinghe, F. Riu, P. Dixit et al., "Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1mediated pathway," International Journal of Cardiology, vol. 202, pp. 13-20, 2016
25. S. Lei, H. Li, J. Xu et al., "Hyperglycemia-induced protein kinase C 2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling," Diabetes, vol. 62, no. 7, pp. 2318-2328, 2013
26. Z. Xia, K. Kuo, P. R. Nagareddy et al., "N-acetylcysteine attenuates PKC2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats," Cardiovascular Research, vol. 73, no. 4, pp. 770-782, 2007
27. H. Li, W. Yao, Z. Liu et al., "Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1/Caveolin-3/STAT3 signaling in diabetic rats," Diabetes, vol. 65, no. 4, pp. 942-955, 2016
28. T.Wang, S. Qiao, S. Lei et al., "N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats," PLOS ONE, vol. 6, no. 8, Article ID e23967, 2011
29. K.T.Keyes, J.Xu, B. Long,C.Zhang,Z.Hu, and Y.Ye, "Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction," American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 4, pp. H1198-H1208, 2010
30. N. Parajuli, Y. Yuan, X. Zheng, D. Bedja, and Z. P. Cai, "Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway," Basic Research in Cardiology, vol. 107, no. 2, p. 248, 2012
31. S.Ma, Y. Wang,Y.Chen, and F.Cao, "The role of the autophagy in myocardial ischemia/reperfusion injury," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1852, no. 2, pp. 271-276, 2015
32. A. B. Gustafsson and R. A. Gottlieb, "Autophagy in ischemic heart disease," Circulation Research, vol. 104, no. 2, pp. 150-158, 2009
33. M. C. Tal, M. Sasai, H. K. Lee, B. Yordy, G. S. Shadel, and A. Iwasaki, "Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2770-2775, 2009
34. S. Sciarretta, V. S. Boppana, M. Umapathi, G. Frati, and J. Sadoshima, "Boosting autophagy in the diabetic heart: A translational perspective," Cardiovascular Diagnosis and Therapy, vol. 5, no. 5, pp. 394-402, 2015
35. B. Wang, Q. Yang, Y.-Y. Sun et al., "Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice," Journal of Cellular and Molecular Medicine, vol. 18, no. 8, pp. 1599-1611, 2014
36. S. C. Bairwa, N. Parajuli, and J. R. Dyck, "The role of AMPK in cardiomyocyte health and survival," Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1862, no. 12, pp. 2199-2210, 2016
37. D. Qi and L. H. Young, "AMPK: energy sensor and survival mechanism in the ischemic heart," Trends in Endocrinology and Metabolism, vol. 26, no. 8, pp. 422-429, 2015
38. A. S. Kim, E. J.Miller, and L. H. Young, "AMP-activated protein kinase: A core signalling pathway in the heart," Acta Physiologica, vol. 196, no. 1, pp. 37-53, 2009
39. R. Xue, S. Lei, Z.-Y. Xia et al., "Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways," Clinical Science, vol. 130, no. 5, pp. 377-392, 2016
40. G. Daz-Araya, D. Nettle, P. Castro et al., "Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion," Critical Care Medicine, vol. 30, no. 2, pp. 417-421, 2002.